Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07385703
What this trial is testing

Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Adenocarcinoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 752
Testing effectiveness (Phase 2)Study completedNCT03793361
What this trial is testing

Phase II Study of Regorafenib as Maintenance Therapy

Who this might be right for
Metastatic Soft Tissue Sarcoma
Centre Oscar Lambret 127
Large-scale testing (Phase 3)Not Yet RecruitingNCT07318883
What this trial is testing

A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Squamous NSCLC
Shanghai Henlius Biotech 720
Not applicableNot Yet RecruitingNCT06738680
What this trial is testing

PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1

Who this might be right for
Non-Small Cell Lung Cancer
University Hospital, Brest 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT07739186
What this trial is testing

A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT05277480
What this trial is testing

Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)

Who this might be right for
Effect of DrugDrugToxicity
Peking University People's Hospital 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750861
What this trial is testing

QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC

Who this might be right for
Pancreatic Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Large-scale testing (Phase 3)UnknownNCT00779714
What this trial is testing

Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC

Who this might be right for
Melanoma
University of Wuerzburg 360
Large-scale testing (Phase 3)Ended earlyNCT03055312
What this trial is testing

Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast Cancer

Who this might be right for
Metastatic Triple Negative Breast Cancer
Sun Yat-sen University 36
Large-scale testing (Phase 3)Study completedNCT02083211
What this trial is testing

Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma

Who this might be right for
Cervical Cancer Recurrent or PersistentPalliative TreatmentMonoclonal Antibody in Cervical Cancer Treatment
National Institute of Cancerología 168
Testing effectiveness (Phase 2)Study completedNCT05918107
What this trial is testing

PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM

Who this might be right for
MPM
Biotheus Inc. 31
Testing effectiveness (Phase 2)Study completedNCT07720011
What this trial is testing

Interim PET/CT-adapted Use of PD-1 Inhibitor Combined With De-escalated Chemotherapy-AVD in Classic Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Peking University People's Hospital 130
Large-scale testing (Phase 3)Ended earlyNCT00968968
What this trial is testing

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Who this might be right for
Cancer
Novartis Pharmaceuticals 37
Large-scale testing (Phase 3)Looking for participantsNCT06532006
What this trial is testing

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

Who this might be right for
Gastroesophageal-junction CancerMonoclonal AntibodyGastric Cancer+1 more
Shanghai Henlius Biotech 550
Testing effectiveness (Phase 2)Looking for participantsNCT06489197
What this trial is testing

AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients

Who this might be right for
ESCCAdvanced Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Active Not RecruitingNCT06132113
What this trial is testing

DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Neoplasms
Boehringer Ingelheim 65
Large-scale testing (Phase 3)Active Not RecruitingNCT04854668
What this trial is testing

Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 748
Not applicableUnknownNCT01282658
What this trial is testing

Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRC

Who this might be right for
Colorectal Cancer
Huazhong University of Science and Technology 200
Large-scale testing (Phase 3)Looking for participantsNCT07229625
What this trial is testing

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)

Who this might be right for
Advanced Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 604
Testing effectiveness (Phase 2)Ended earlyNCT01356368
What this trial is testing

Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
National Guard Health Affairs 3
Next Page